Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group
Titel:
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group
Auteur:
Mountzios, Giannis Emmanouilidis, Christos Vardakis, Nikolaos Kontopodis, Emmanouil Hatzidaki, Dora Popis, Evagelos Karachaliou, Niki Kotsakis, Athanassios Agelidou, Maria Georgoulias, Vassilis